Guidelines for good database selection and use in pharmacoepidemiology research
暂无分享,去创建一个
Brian Sauer | Jeffrey S. Brown | A. Bourke | M. Reynolds | B. Sauer | Jeffrey S. Brown | G. Hall | Alison Bourke | Gillian C. Hall | Matthew W. Reynolds | Robert Lo Casale | Robert Lo Casale
[1] Sebastian Schneeweiss,et al. Multivariate‐adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases , 2010, Pharmacoepidemiology and drug safety.
[2] R. Platt,et al. Distributed Health Data Networks: A Practical and Preferred Approach to Multi-Institutional Evaluations of Comparative Effectiveness, Safety, and Quality of Care , 2010, Medical care.
[3] N. Dreyer,et al. Registries for Evaluating Patient Outcomes: A User’s Guide , 2010 .
[4] David Atkins,et al. Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[5] M. Epstein,et al. Guidelines for good pharmacoepidemiology practices (GPP) , 2008 .
[6] R. Hughes,et al. Guillain-Barré syndrome , 1994, The Lancet.
[7] L. Smeeth,et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review , 2010, British journal of clinical pharmacology.
[8] Douglas G Altman,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. , 2014, International journal of surgery.
[9] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.
[10] Peter Davey,et al. A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[11] G. Hall. Validation of death and suicide recording on the THIN UK primary care database , 2009, Pharmacoepidemiology and drug safety.
[12] W. Bilker,et al. Descriptive analyses of the integrity of a US Medicaid claims database , 2003, Pharmacoepidemiology and drug safety.